Now livetag icon
What will define the 2026 holiday season? 🔎 See how shoppers are deciding. Download the report →banner icon
Corvus Pharmaceuticals, Inc.

March 2026

  • Home
  • Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, ... Market Share Analysis for March 2026

corvus pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.
Year Founded2014
Employees51 - 200
Annual Revenue$5M - $10M
corvuspharma.com
Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. (including company regionals)
  • corvuspharma.com
    corvuspharma.com
See more website traffic and engagement information

Corvus Pharmaceuticals, Inc. Revenue up to March 2026 is 5M - 10M

revenue generated by Corvus Pharmaceuticals, Inc. top domains

Corvus Pharmaceuticals, Inc. top domains revenue over 3 years

Revenue for Corvus Pharmaceuticals, Inc. top domains

corvuspharma.comcorvuspharma.com5M - 10M
See more with Sales Intelligence

Total visits to Corvus Pharmaceuticals, Inc.'s top domains

Understand Corvus Pharmaceuticals, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Corvus Pharmaceuticals, Inc.'s top domains

Analyze Corvus Pharmaceuticals, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
corvuspharma.comcorvuspharma.com00:00:22
See more with Sales Intelligence

Avg. pageviews on Corvus Pharmaceuticals, Inc.'s top domains

See how Corvus Pharmaceuticals, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Corvus Pharmaceuticals, Inc. top competitors by domain

Top similar sites in March 2026, ranked by their affinity

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Corvus Pharmaceuticals, Inc.

These are the website technologies, by industry, used by Corvus Pharmaceuticals, Inc. top domains

Advertising (1)

PubMatic

PubMatic

Audio Video Media (1)

Vimeo

Vimeo

Content Management System (1)

Atlassian Cloud

Atlassian Cloud

Conversion & Analytics (1)

Google Analytics

Google Analytics

More Technologies

7

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Corvus Pharmaceuticals, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCorvus Pharmaceuticals, Inc. attends event Oppenheimer 36th Annual Healthcare Life Sciences Conference.SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) - Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and present a corporate overview at Oppenheimer 36th Annual Healthcare Life Sciences Conference which is being held virtually.
NewsCorvus Pharmaceuticals, Inc. attended event 67th American Society of Hematology (ASH) Annual Meeting & Exposition on Nov 3rd '25.SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) - Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1/1b trial of soquelitinib in patients with T cell lymphoma will be presented in an oral session at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition, which is taking place December 6-9, 2025 in Orlando, FL.
NewsCorvus Pharmaceuticals, Inc. hired David Moore as Board of Directors on Oct 2nd '25.SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) - Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that David Moore, Executive Vice President, US Operations at Novo Nordisk A/S and President at Novo Nordisk Inc., has been appointed to the company's Board of Directors.

See all Corvus Pharmaceuticals, Inc. signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.